2-232539976-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_005199.5(CHRNG):​c.56-16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000742 in 1,614,116 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0038 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00042 ( 5 hom. )

Consequence

CHRNG
NM_005199.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -3.27

Publications

0 publications found
Variant links:
Genes affected
CHRNG (HGNC:1967): (cholinergic receptor nicotinic gamma subunit) The mammalian muscle-type acetylcholine receptor is a transmembrane pentameric glycoprotein with two alpha subunits, one beta, one delta, and one epsilon (in adult skeletal muscle) or gamma (in fetal and denervated muscle) subunit. This gene, which encodes the gamma subunit, is expressed prior to the thirty-third week of gestation in humans. The gamma subunit of the acetylcholine receptor plays a role in neuromuscular organogenesis and ligand binding and disruption of gamma subunit expression prevents the correct localization of the receptor in cell membranes. Mutations in this gene cause Escobar syndrome and a lethal form of multiple pterygium syndrome. Muscle-type acetylcholine receptor is the major antigen in the autoimmune disease myasthenia gravis.[provided by RefSeq, Sep 2009]
CHRNG Gene-Disease associations (from GenCC):
  • autosomal recessive multiple pterygium syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet
  • CHRNG-associated hypo-akinesia disorder of prenatal onset
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
  • transient neonatal myasthenia gravis
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 2-232539976-C-T is Benign according to our data. Variant chr2-232539976-C-T is described in ClinVar as [Benign]. Clinvar id is 3016305.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00383 (584/152332) while in subpopulation AFR AF = 0.0129 (535/41580). AF 95% confidence interval is 0.012. There are 2 homozygotes in GnomAd4. There are 284 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNGNM_005199.5 linkc.56-16C>T intron_variant Intron 1 of 11 ENST00000651502.1 NP_005190.4 P07510-1A0A6F7YAP6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNGENST00000651502.1 linkc.56-16C>T intron_variant Intron 1 of 11 NM_005199.5 ENSP00000498757.1 P07510-1
CHRNGENST00000389492.3 linkc.56-16C>T intron_variant Intron 1 of 10 1 ENSP00000374143.3 P07510-2
CHRNGENST00000485094.1 linkn.77-16C>T intron_variant Intron 1 of 4 1

Frequencies

GnomAD3 genomes
AF:
0.00384
AC:
584
AN:
152214
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0129
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00116
AC:
291
AN:
250078
AF XY:
0.00105
show subpopulations
Gnomad AFR exome
AF:
0.0144
Gnomad AMR exome
AF:
0.000897
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000979
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000619
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000420
AC:
614
AN:
1461784
Hom.:
5
Cov.:
33
AF XY:
0.000380
AC XY:
276
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.0131
AC:
437
AN:
33478
American (AMR)
AF:
0.000872
AC:
39
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.000403
AC:
16
AN:
39700
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53350
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000387
AC:
43
AN:
1111992
Other (OTH)
AF:
0.000944
AC:
57
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00383
AC:
584
AN:
152332
Hom.:
2
Cov.:
33
AF XY:
0.00381
AC XY:
284
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0129
AC:
535
AN:
41580
American (AMR)
AF:
0.00216
AC:
33
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00154
AC:
8
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68016
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00172
Hom.:
0
Bravo
AF:
0.00428
Asia WGS
AF:
0.00346
AC:
12
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Mar 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.12
DANN
Benign
0.76
PhyloP100
-3.3
PromoterAI
0.019
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139127435; hg19: chr2-233404686; API